glp 1 approval GLP-1s Continued growth for GLP-1 receptor

2 Changes in ingestive behaviour at week 3

The condition is diagnosed using Body Mass Index (BMI), with overweight defined as a BMI of 25 or greater, and obesity as 30 or greater in adults

Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2021

Patients with prediabetes, obesity, or metabolic syndrome could potentially receive treatment sooner, particularly if clinical evidence continues to support cardiovascular and renal benefits

111 Reduced production of pro-inflammatory cytokines, blocked NF-B signaling, and increased regulatory T-cell activity are some of the mechanisms through which GLP-1RA protects against intestinal inflammation in early-stage IBD models 112 (Figure 1)